Ocular Therapeutix (OCUL) Operating Expenses (2013 - 2026)

Ocular Therapeutix's Operating Expenses history runs 14 years deep, the most recent figure standing at $104.1 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 39.55% year-over-year to $104.1 million; the TTM figure through Mar 2026 stood at $351.5 million (up 33.27% YoY), while the FY2025 annual figure was $322.0 million, up 36.71% from the prior year.
• Operating Expenses was $104.1 million for Q1 2026 at Ocular Therapeutix, up from $83.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $104.1 million in Q1 2026 to a low of $31.0 million in Q1 2022.
• Historically, Operating Expenses has averaged $54.9 million across 5 years, with a median of $46.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses rose 0.73% in 2022, then jumped 94.14% in 2024.
• A 5-year view of Operating Expenses shows it stood at $33.4 million in 2022, then gained by 4.23% to $34.9 million in 2023, then soared by 94.14% to $67.7 million in 2024, then rose by 22.69% to $83.0 million in 2025, then climbed by 25.44% to $104.1 million in 2026.
• The last three Operating Expenses figures came in at $104.1 million (Q1 2026), $83.0 million (Q4 2025), and $83.2 million (Q3 2025), per Business Quant data.